Top Industry Leaders in the Nano Biotechnology Market
Latest Nano Biotechnology Companies Updates:
Agilent Technologies: Acquisition of Spatial Biosciences in October 2023 strengthens its position in the spatial genomics market and offers integrated solutions for tissue microarray analysis using nanotechnology.
Applied Microarrays: Merger with Bio-Techne in December 2023 forms a leading provider of microarray and protein array technologies, potentially driving nano-based protein analysis solutions.
Tarveda Therapeutics: Developed a nanoparticle-based platform for targeted delivery of anti-cancer drugs, demonstrating improved efficacy and reduced side effects in preclinical trials.
Cellectis: Partnered with Evotec to develop chimeric antigen receptor (CAR) T-cell therapies using its proprietary nanobiotechnology platform, aiming for enhanced targeting and efficacy in cancer treatment.
NanoString Technologies: Unveiled its GeoMx™ DSP instrument, featuring high-definition spatial transcriptomics capabilities using nano-scale probes, offering deep insights into tissue organization and disease processes.
Illumina, Inc.: Developed a new sequencing technology utilizing nanopores for rapid and cost-effective DNA sequencing, potentially revolutionizing genetic diagnostics and personalized medicine.
List of Nano Biotechnology Key companies in the market:
-
Ablynx (Belgium),
-
Nami Therapeutics (US)
-
Celgene Corporation (US)
-
Nanophase Technologies Corporation (US)
-
Sigma-Aldrich (US)
-
SkyePharma Pharmaceuticals (France)
-
Nanobiotix(France)
-
Dabur Pharma (India)